Nike's Transgender Youth Study Controversy: What We Know

The controversy began when Dr. Kathryn Ackerman and Joanna Harper publicly stated that Nike was helping to fund a study on youth transgender athletes. This study aimed to examine the effects of puberty blockers and hormone therapy on athletic performance. The *New York Times* also reported Nike's involvement in an article about transgender volleyball player Blaire Fleming.

Nike's recent statement contradicts these earlier reports, creating confusion about the company's actual involvement. The lack of detailed information from Nike has fueled speculation and criticism. Jennifer Sey, founder of XX-XY Athletics, strongly condemned the study, arguing that it is degrading to women and girls to frame the issue as whether "retained male advantage" can be minimized to allow fair competition.

The situation remains unclear, with key questions unanswered: Did Nike actually provide any funds? When was the decision made not to move forward with the study? Who made that decision, and why?

Reports initially indicated Nike was funding the study, but Nike now claims the study was never initialized.

Critics argue the study is unethical and degrades women by focusing on minimizing male advantages in women's sports.

Whether Nike provided funds, when the decision was made to halt the study, and the reasons behind that decision.

What do you think about Nike's involvement in this study? Share your thoughts in the comments below!

Share this article with others who need to stay ahead of this trend!